William Belden

Q: What is William Belden email address?

Email William Belden at william.belden@apheonbio.com. This email is the most updated William Belden email found in 2026.

Q: How to contact William Belden?

To contact William Belden send an email to william.belden@apheonbio.com. (updated on October 24, 2024)

President, CSO and Professor Emeritus at Apheon Bioscience | Rensselaer, New York, United States

About William Belden

William Belden currently serves as the President and Chief Scientific Officer (CSO) of Apheon Bioscience, a pioneering company dedicated to advancing the life sciences research sector through cutting-edge recombinant molecular biology technologies. In this role, he leverages his extensive expertise in biochemistry, protein purification, and immunoassays to drive innovative projects aimed at identifying novel disease biomarkers. These biomarkers are crucial for the development of first-in-class immunotherapies, positioning Apheon Bioscience at the forefront of therapeutic advancements.

Under William's leadership, Apheon Bioscience has embarked on several key projects that focus on affinity-based tumor antigen and biomarker discovery services. These initiatives not only enhance the understanding of complex disease mechanisms but also facilitate the identification of therapeutic leads that can be translated into clinical applications. His commitment to bridging the gap between academic research and practical application is evident in the collaborative partnerships Apheon fosters with both large pharmaceutical companies and emerging biotech firms.

Prior to his tenure at Apheon, William was an Associate Professor with tenure at Rutgers University, where he cultivated a robust academic background in biomedical research. His experience in university teaching and research development has equipped him with a unique perspective on the challenges and opportunities within the life sciences field. With a strong foundation in statistics and assay development, William is adept at guiding teams through the intricacies of recombinant DNA technologies and phage display methodologies, ensuring that Apheon remains a leader in the quest for innovative therapeutic solutions. His dual role as a Professor Emeritus further underscores his dedication to education and mentorship, fostering the next generation of scientists in the dynamic landscape of biomedical research.

William Belden Work